Connexion
[Deal du jour] Après une première Pixel Watch loin d'être parfaite, Google apporte des nouveautés bienvenues à cette seconde itération. La Pixel Watch 2 corrige les erreurs de son ainée et devient un modèle bien plus intéressant, surtout en promotion.
Depuis le 15 avril 2024, Île-de-France Mobilités propose aux propriétaires d'une montre Galaxy Watch de monter à bord d'un métro, d'un tramway ou d'un bus avec leur poignée. L'Apple Watch sera la prochaine servie.
Chez Amazon, la montre Samsung Galaxy Watch 4 voit son prix chuter de 23 % et est donc affichée à 138 € au lieu de presque 180 €.
L’article Samsung Galaxy Watch 4 : la montre connectée est à petit prix chez Amazon est apparu en premier sur Toms Guide.
galaxy-watch-4-promo-rueducommerce
full
galaxy-watch-4-promo-rueducommerce
thumbnail
Après des années de résistance, Apple autorise finalement les émulateurs sur l'App Store. Cela donne déjà quelques idées à des joueurs.
Un brevet déposé par Apple imagine un détecteur de noyade intégré à l'Apple Watch. En cas d'immersion prolongée sous l'eau, la montre pourrait déclencher une alarme sur tous les appareils environnants, pour réclamer de l'aide.
Enlarge / A blurry, ghostly Persona in visionOS 1.0. They should at least look less bad in visionOS 1.1. (credit: Samuel Axon)
Apple has released a long list of medium-sized software updates for most of its devices today. The macOS Sonoma 14.4, watchOS 10.4, tvOS 17.4, and visionOS 1.1 updates are all available now, and most of them add at least one or two major features as they fix multiple bugs and patch security vulnerabilities.
The visionOS 1.1 release is the first major update for Apple's newest operating system, and as our coverage of the headset has demonstrated, there's still plenty of low-hanging fruit to fix. Most notably for people who are trying to use the headset for work meetings, Apple says that there have been multiple changes to the look of Personas, the 3D avatars that show up in your place when you're video chatting with the Vision Pro on your face. The update improves "hair and makeup appearance," "neck and mouth representation," and "rendering of the eyes," and while it's clear that it's an improvement over the 1.0 release of Personas, the core uncanniness still seems to be intact. The Persona feature is still labeled as a beta.
Apple has also made tweaks to the appearance and functionality of the headset's virtual keyboard, improved the Virtual Display feature's Mac connectivity, and added a handful of mobile device management features for IT administrators.
[Deal du jour] La Galaxy Watch 5 Pro est une montre connectée haut de gamme de Samsung, bourrée de fonctionnalités. Avec un joli design et un bon suivi de santé, cette montre à tout pour plaire, surtout à presque moitié prix.
Enlarge / The Fitbit Charge 5 came out in September 2021. (credit: Google)
Fitbit owners are getting frustrated with Charge 5 fitness trackers quickly losing their charge and, in some cases, exhibiting additional problems. Google has denied that the problems are tied to firmware updates. But users remain skeptical, and some are fed up with Google's limited response to a recurring problem.
On December 21, Fitbit announced Charge 5 firmware update 194.91 on its support forum. On paper, the update seemed typical, promising things like new clock faces, support for right-to-left text, and "bug fixes and improvements," per the release notes.
But by early January, there were complaints on the forum from people who said they updated their Charge 5 and then saw their device's battery suddenly drain much faster. Examples include one user claiming their battery life drains from 100 percent to 0 percent in 25 minutes and others saying their Charge 5 lasts about 12 hours. Most say their Charge 5 no longer lasts for a full day despite staying powered for days between charges before the update. The problems led a user going by Ge0ffh to call his device "completely unusable."
[Deal du jour] Sortie en même temps que l'iPhone 15, la Watch Series 9 est une nouvelle itération de la montre connectée d'Apple. Elle vient avec quelques nouveautés et surtout, un prix plus doux pour les soldes.
Enlarge / The iPhone 15 Pro. (credit: Samuel Axon)
Apple yesterday released iOS and iPadOS 17.3 as well as watchOS 10.3, tvOS 17.3, and macOS Sonoma 14.3 for all supported devices.
iOS 17.3 primarily adds collaborative playlists in Apple Music, and what Apple calls "Stolen Device Protection." Collaborative playlists have been on a bit of a journey; they were promised as part of iOS 17, then added in the beta of iOS 17.2, but removed before that update went live. Now they're finally reaching all users.
When enabled, Stolen Device Protection requires Face ID or Touch ID authentication "with no passcode fallback" for some sensitive actions on the phone.
Enlarge / The Apple Watch Ultra 2. (credit: Apple)
Starting today, if you buy an Apple Watch Series 9 or Watch Ultra 2 it won’t be able to tell you your blood oxygen levels, a feature that Apple heavily touted when first introducing the capability in 2020. Although the watches will be less capable than watches of the same model sold before today, Apple is selling the pared-down watches at the same prices as before.
On Wednesday, the US Court of Appeals for the Federal Circuit denied [PDF] Apple’s request that an import ban on the smartwatches be lifted for the duration of Apple’s appeal of the ruling that blocked the watches. Apple expects its appeal to take at least a year to be resolved.
In its ruling, the court said:
Following the latest legal defeat in Apple's ongoing patent infringement fight over blood oxygen sensors, the company is set to remove its blood oxygen measurement feature from its Watch Series 9 and Watch Ultra 2 sold in the U.S. The decision comes after the U.S. Court of Appeals for the Federal Circuit declined to extend a pause on an import ban imposed by the U.S. International Trade Commission (USITC) last year, making way for the ban to finally take effect.
The legal setback stems from a ruling that Apple's watches infringed on patents related to blood oxygen measurement that belong to Masimo, which sued Apple in 2020. The U.S. Court of Appeals' decision means that Apple must stop selling watches with this feature while the appeal, which could last a year or more, is in progress.
As the ruling bars Apple from selling additional watches with this feature, the company has been left with a handful of options to comply with the ruling. Ceasing watch sales entirely certainly works – though is unpalatable for obvious reasons – which leaves Apple with removing the feature from their watches in some manner. Any hardware retool to avoid infringing upon Masimo's patents would take upwards of several quarters, so for the immediate future, Apple will be taking the unusual step of disabling the blood oxygen sensor feature in software instead, leaving the physical hardware on-device but unused.
The new, altered Apple Watch models will be available from Thursday in Apple's retail and online stores. Despite the change, the company maintains that the USITC's decision is erroneous and continues to appeal. Apple stresses that the blood oxygen feature will still be available in models sold outside the U.S., and perhaps most critically, watches sold in the U.S. before this change will keep their blood oxygen measuring capability.
"Pending the appeal, Apple is taking steps to comply with the ruling while ensuring customers have access to Apple Watch with limited disruption," the company said in a statement published by Bloomberg.
It is noteworthy that the Patent Trial and Appeal Board invalidated 15 of 17 Masimo's patents it reviewed, a verdict that Masimo is currently challenging. In Masimo's trial for trade secret misappropriation last May, a judge ruled out half of Masimo's 10 allegations due to a lack of adequate evidence. Regarding the remaining allegations, most jurors agreed with Apple's position, but the trial ultimately ended with an 11-1, non-unanimous decision, resulting in a mistrial. Scheduling of a new trial to settle the matter is still pending. In the meantime, Apple has been left with little choice but to downgrade its products to keep selling them in the U.S.
Enlarge / The Apple Watch Series 9. (credit: Apple)
Apple has developed a backup plan for if the Apple Watch Series 9 and Ultra 2 are import banned again. As it currently appeals the US International Trade Commission's (ITC's) ruling that its watches violate a patent owned by Masimo, Apple has come up with a software workaround that strips its current smartwatches of their controversial blood oxygen monitoring capabilities.
In January 2023, the ITC ruled that the Watch violated one of California-headquartered Masimo’s light-based pulse oximetry patents. The Apple Watch Series 6, which came out in 2020, was the first Apple smartwatch to use a pulse oximeter sensor.
Facing a US import ban of the current Watch Series 9 and Watch Ultra 2, both released in September 2023, Apple started pulling the smartwatches on December 21. But on December 27, Apple, which filed its appeal against the ITC’s ruling on December 26 (after US President Joe Biden declined to overrule the ITC ruling), received an emergency interim stay from the US Court of Appeals for the Federal Circuit, allowing it to continue selling the Watch.
Apple a obtenu un sursis quant à l'interdiction de la vente de ses dernières montres connectées. L'Apple Watch Series 9 et l'Apple Watch Ultra 2 sont de nouveau disponibles aux États-Unis. Pour l'heure, ce n'est encore que temporaire.
Enlarge / The Apple Watch Series 9 released in September 2023. (credit: Apple)
Just before Christmas, Apple pulled two of its latest smartwatches from stores. The cause was not an unwelcome visit from the ghost of mechanical timepieces past but the International Trade Commission, which found that the California-based computer maker had infringed on some patents, resulting in the ITC banning the import of said watches. Yesterday, Reuters reported that Apple filed an emergency request for the courts to lift the ban and will appeal the ITC ruling.
And today, the US Court of Appeals for the Federal Circuit granted Apple's wish, pausing the ban while it considers the tech company's argument.
Apple's watch problems started back in January. That's when a court found that the light-based pulse oximetry sensor (found on the back of the watches) infringed patents held by Masimo, a medical device manufacturer also based in California.
Enlarge / The Apple Watch Ultra 2. (credit: Apple)
Apple is banned from selling the Watch Series 9 and Watch Ultra 2 in the US after President Joe Biden’s administration refused to grant a reprieve from a trade tribunal’s decision that it had infringed another company’s patents.
Apple confirmed on Tuesday it had appealed against the earlier ruling from the US International Trade Commission, which stems from a patent dispute with health technology company Masimo.
Biden’s administration had 60 days from the ITC decision, which was handed down in October, to decide whether to allow it to take effect. The authority to decide whether to intervene was delegated by the White House to the US trade representative, Katherine Tai.
La Maison-Blanche avait jusqu'au 25 décembre pour annuler la décision de justice qui interdit l'importation des dernières Apple Watch aux États-Unis. Sans aide présidentielle, Apple devra trouver d'autres solutions légales.
En 2023, Withings, spécialiste des objets axés sur la santé, a lancé la ScanWatch 2, une montre hybride bardée de capteurs au design soigné.
Aux États-Unis seulement, Apple indique que ses Watch Series 9 et Watch Ultra 2 sont « actuellement indisponibles ». Une première historique dans l'histoire de la marque, rattrapée pour une histoire de brevets. La sortie de cette crise est encore incertaine.
Apple on Monday said it would pause sales of its Watch Series 9 and Ultra 2 in the U.S. due to an ongoing patent dispute. The patents in question cover the blood oxygen feature in the watches, and belong to medical technology company Masimo. Apple itself said it would halt sales of its latest oxygen sensor-equipped smart watches online starting December 21, and in retail starting December 25.
The dispute's roots lie in Masimo's claims that Apple's blood oxygen sensor infringes on 15 of its patents. The ITC ruling, announced in October, upheld a judge's decision from January and triggered a 60-day Presidential Review Period, which will be expiring on December 25. Despite the possibility of a veto from President Biden, Apple decided to halt sales of its latest smart watches as a proactive measure.
Sales of the affected Apple Watch models will cease on Apple's website after 3 PM ET on December 21 and in Apple's retail stores after December 24. Notably, this ban is exclusive to Apple’s direct sales channels; third-party retailers like Amazon and Best Buy can continue selling the devices until December 25. This limited scope of the ban provides a brief window for consumers to purchase these models from alternative sources in time for Christmas.
Behind the scenes, Apple is actively contesting the ruling and exploring various legal and technical options to ensure the continued availability of its watches. The company argues that the ban could adversely affect both consumers and the broader economy, given the significant revenue generated by Apple's wearables business, especially during the Q1 2023 holiday quarter. Meanwhile, Masimo maintains its stance, viewing the ITC's ban as a strong message about adhering to patent laws.
The Patent Trial and Appeal Board evaluated 17 Masimo patents, invalidating 15, a decision that Masimo is now contesting. During Masimo's trade secret misappropriation trial in May, a judge dismissed half of its 10 claims due to insufficient evidence. Of the remaining claims, a majority of jurors sided with Apple, but with one dissenting, they could not reach a unanimous verdict, leading to a mistrial. A date for a new trial has yet to be set.
Currently, there is no defined duration for the unavailability of Apple Watch Ultra 2 and Series 9. While a veto from the Biden administration remains possible, Apple plans to appeal the ITC's decision with the U.S. Court of Appeals for the Federal Circuit after the Presidential Review Period, starting December 26. This appeal will not postpone the sales and import ban on these models since the disputed Masimo patents are valid until August 2028, but if the court sides with Apple, the company could return its products to the U.S. market. Apple has alternative options, such as negotiating a settlement or a licensing deal with Masimo. Additionally, the company could redesign its smartwatches to bypass the two Masimo patents, possibly by updating Apple Watch's firmware.
It should be noted that the ITC's decision is specific to models featuring the blood oxygen monitoring technology. As a result, the Apple Watch SE, which lacks this feature, remains unaffected and will continue to be available.
The ban's impact is expected to affect Apple's earnings, yet it does not affect Apple Watches already sold or their functionality. Existing models with the blood oxygen sensor, introduced with the Apple Watch Series 6 in 2020, will continue to operate as usual. Furthermore, the ITC's order permits service, repair, or warranty work on units sold before December 25.
Aux États-Unis, les Apple Watch Series 9 et Ultra 2, lancées en septembre, vont être retirées de la vente. Une décision historique liée à un conflit de brevets qui pourrait obliger Apple à agir vite. Parmi les changements évoqués, un changement d'algorithme pour changer le fonctionnement du capteur d'oxygène… ou un redesign complet de la montre.
Lateo.net - Flux RSS en pagaille (pour en ajouter : @ moi) 
